Military’s testosterone screening program could lead to overtreatment and side effects, including impaired T productionJuly 27, 2026
Research Indian drugmaker Cipla's Q1 profit misses estimatesBy Healthcare Propulsion StaffJuly 23, 20260 Cipla , one of India’s largest drugmakers by revenue, reported a bigger-than-expected 39.2% fall in first-quarter profit, its third consecutive…
